瑞信:升中海油服(2883.HK)目標價至15港元 評級“跑贏大市”
瑞信發表報告表示,對於中海油服(2883.HK)
就子公司對Equinor興訟一事,已達成庭外和解並簽署和解協議,且雙方簽署一項有助於鞏固雙方合作關係的框架協議,認為對公司發展正面,有助加強中海油服於海外的業務。
報告又指,Equinor將向中海油服支付1.88億美元,預期將有近10億元人民幣一次性收益於今年內入帳,因此該行上調其2020年度盈利預測約20%,目標價相應由13.7港元上調至15港元,重申“
跑贏大市
”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.